FDAsafety guidance83% confidence
Guidance Documents for Rare Disease Drug Development
Source: FDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable safety guidance decision relevant to pilonidal sinus disease treatments.
Regulatory Analysis
Supporting Context
- Therapeutic area
- Surgery · Pilonidal Sinus Disease
- Sub-indication
- General
Related signal: Trial Compares Laser Ablation vs Crystallized Phenol for Pilonidal Sinus Disease